- Lobbying
- Lobbying by Emergent BioSolutions, Inc.
Lobbying Relationship
Bills mentioned
H.R.2379: State Opioid Response Grant Authorization Act of 2021
Sponsor: David Trone (D-Md.)
H.R.2366: STOP Fentanyl Act of 2021
Sponsor: Ann McLane Kuster (D-N.H.)
S.1457: STOP Fentanyl Act of 2021
Sponsor: Edward J. Markey (D-Mass.)
H.R.5224: Preventing Overdoses and Saving Lives Act of 2021
Sponsor: French Hill (R-Ark.)
H.R.6119: Further Extending Government Funding Act
Sponsor: Rosa DeLauro (D-Conn.)
H.R.2471: Consolidated Appropriations Act, 2022
Sponsor: Hakeem Jeffries (D-N.Y.)
H.R.6833: Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Sponsor: Angie Craig (D-Minn.)
H.R.2471: Vote Without Fear Act
Sponsor: Raul Ruiz (D-Calif.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Bryan Lanza | n/a |
Toby Moffett | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Office of Administration
Office of Administration
Office of Administration
Office of Administration
Office of Administration
Office of Administration
Office of Administration
Office of Administration
Office of Administration
Office of Administration
Office of Administration
Office of Administration
Office of Administration
Office of Administration
Office of Administration
Health & Human Services - Dept of (HHS)
Health & Human Services - Dept of (HHS)
Health & Human Services - Dept of (HHS)
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate